JP2022501423A5 - - Google Patents
Info
- Publication number
- JP2022501423A5 JP2022501423A5 JP2021538933A JP2021538933A JP2022501423A5 JP 2022501423 A5 JP2022501423 A5 JP 2022501423A5 JP 2021538933 A JP2021538933 A JP 2021538933A JP 2021538933 A JP2021538933 A JP 2021538933A JP 2022501423 A5 JP2022501423 A5 JP 2022501423A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical
- vesicle
- cholesterol
- formulation
- pharmaceutical agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1814959.1A GB201814959D0 (en) | 2018-09-14 | 2018-09-14 | Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses |
| GB1814959.1 | 2018-09-14 | ||
| PCT/GB2019/000134 WO2020053541A1 (en) | 2018-09-14 | 2019-09-13 | Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501423A JP2022501423A (ja) | 2022-01-06 |
| JP2022501423A5 true JP2022501423A5 (https=) | 2022-09-21 |
| JP7487892B2 JP7487892B2 (ja) | 2024-05-21 |
Family
ID=64013381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538933A Active JP7487892B2 (ja) | 2018-09-14 | 2019-09-13 | 医薬ベシクル製剤を調製するための方法、ならびに関連する製品および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11524080B2 (https=) |
| EP (1) | EP3849511B1 (https=) |
| JP (1) | JP7487892B2 (https=) |
| AU (1) | AU2019337456B9 (https=) |
| CA (1) | CA3113047A1 (https=) |
| DK (1) | DK3849511T3 (https=) |
| GB (2) | GB201814959D0 (https=) |
| WO (1) | WO2020053541A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115916175A (zh) * | 2020-04-02 | 2023-04-04 | 南方研究院 | 作为针对甲病毒属的有效抗病毒剂的新型2-嘧啶酮类似物 |
| CN116350588B (zh) * | 2023-01-13 | 2024-09-24 | 华中科技大学 | 一种载抗生素微生物囊泡及其制备方法和应用 |
| GB202303291D0 (en) * | 2023-03-07 | 2023-04-19 | Secr Defence | Medicament and medicament combination for use in the treatment of infectious disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4323561A (en) * | 1977-09-06 | 1982-04-06 | Temple University Of The Commonwealth System Of Higher Education | Process of enhancing immmunogenic response in mammals by the administration of synthetic glycolipid adjuvants |
| JPH04159216A (ja) * | 1990-10-22 | 1992-06-02 | Japan Tobacco Inc | グルコサミン誘導体を膜材として含有するリポソーム |
| GB9515868D0 (en) | 1995-08-02 | 1995-10-04 | Proteus Molecular Design | Therapeutic method |
| US7648982B2 (en) * | 2003-02-28 | 2010-01-19 | Ym Biosciences Inc. | Opioid delivery system |
| BRPI0910686A2 (pt) * | 2008-04-21 | 2015-09-29 | Tissue Regeneration Therapeutics Inc | células perivasculares do cordão umbilical humano geneticamente modificadas para a profilaxia contra agentes biológicos e químicos ou para o tratamento dos mesmos. |
| JP5854559B2 (ja) | 2009-07-06 | 2016-02-09 | ヴァリエーション バイオテクノロジーズ インコーポレイテッド | 小胞を調製する方法及びこれから製造される製剤 |
| CA2803282C (en) * | 2009-07-06 | 2018-05-01 | David E. Anderson | Methods for preparing vesicles and formulations produced therefrom |
| GB0916630D0 (en) | 2009-09-22 | 2009-11-04 | Secr Defence | Antibody |
| WO2012006367A2 (en) * | 2010-07-06 | 2012-01-12 | Variation Biotechnologies, Inc. | Compositions and methods for treating influenza |
| WO2013059617A1 (en) | 2011-10-21 | 2013-04-25 | Ndsu Research Foundation | Liposome compositions and methods of use |
| US20140328876A1 (en) * | 2011-11-18 | 2014-11-06 | Variation Biotechnologies Inc. | Synthetic derivatives of mpl and uses thereof |
| AU2013208693B2 (en) * | 2012-01-12 | 2017-12-07 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
| EP2806894A4 (en) * | 2012-01-27 | 2015-11-04 | Variation Biotechnologies Inc | METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS |
| US9969794B2 (en) * | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| US9539273B2 (en) * | 2012-08-04 | 2017-01-10 | Edh Biotech Corp | Targeted delivery of anti-fungal agents |
| WO2015061025A1 (en) | 2013-10-22 | 2015-04-30 | Aradigm Corporation | Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile |
| WO2015156904A1 (en) | 2014-04-08 | 2015-10-15 | Aradigm Corporation | Liposomes that form drug nanocrystals after freeze-thaw |
| MA40428A (fr) * | 2014-08-14 | 2016-02-18 | L E A F Holdings Group Llc | Médicament à affinité encapsulé dans un liposome |
-
2018
- 2018-09-14 GB GBGB1814959.1A patent/GB201814959D0/en not_active Ceased
-
2019
- 2019-09-12 GB GB1913128.3A patent/GB2578678B/en active Active
- 2019-09-13 AU AU2019337456A patent/AU2019337456B9/en active Active
- 2019-09-13 DK DK19778580.1T patent/DK3849511T3/da active
- 2019-09-13 CA CA3113047A patent/CA3113047A1/en active Pending
- 2019-09-13 US US17/273,059 patent/US11524080B2/en active Active
- 2019-09-13 WO PCT/GB2019/000134 patent/WO2020053541A1/en not_active Ceased
- 2019-09-13 EP EP19778580.1A patent/EP3849511B1/en active Active
- 2019-09-13 JP JP2021538933A patent/JP7487892B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025015674A (ja) | 光免疫療法のための組成物、組み合わせおよび関連方法 | |
| US20170165375A1 (en) | Antibiotic protocells and related pharmaceutical formulations and methods of treatment | |
| JP6050822B2 (ja) | ナノ粒子、ナノ粒子の調製のための処理、および癌治療および食品関連化合物を含む医療分野における両親媒性分子または疎水性分子ための担体としてのナノ粒子の使用 | |
| US20250255978A1 (en) | Drug-delivery nanoparticles and treatments for drug-resistant cancer | |
| JP2022501423A5 (https=) | ||
| BG108274A (bg) | Конюга'и о' хидрок'иалкил'корбяла (has) и ак'ив...н ингр...ди...н' | |
| CN106604750A (zh) | 治疗骨髓瘤 | |
| CA2942234A1 (en) | Liposomal compositions for mucosal delivery | |
| CN105163743A (zh) | 用于治疗幽门螺杆菌的药物组合物 | |
| CN110573166A (zh) | 用于癌症治疗的吉西他滨衍生物 | |
| EP3697767A1 (en) | Compounds and methods for treating cancer | |
| JP4513007B2 (ja) | 薬物吸収性改善剤 | |
| AU779922B2 (en) | Formulations for parenteral use of estramustine phosphate and amino acids | |
| JP7487892B2 (ja) | 医薬ベシクル製剤を調製するための方法、ならびに関連する製品および使用 | |
| JP2026001029A (ja) | がん治療のための化学療法剤とα－ラクトアルブミン－オレイン酸複合体の組合せ | |
| WO2017097783A1 (en) | Novel adjuvant formulations | |
| JPH0136445B2 (https=) | ||
| CN120826242A (zh) | 抗cd20抗体药物偶联物在制备治疗套细胞淋巴瘤的药物中的用途 | |
| CN110787301A (zh) | CTLA-4 Aptamer靶向共负载PD-1 siRNA纳米颗粒及其制备和应用 | |
| JP7149991B2 (ja) | 発泡剤を含む抗微生物組成物 | |
| CN105263499B (zh) | 用于癌症治疗的ro5503781、卡培他滨和奥沙利铂的组合 | |
| CN115721732A (zh) | 抗体偶联药物的药物组合物、制剂及其制备方法、用途 | |
| CN1177583C (zh) | 具有改进药理学性质的非肠胃道使用的雌莫司汀磷酸盐制剂 | |
| CN1374857A (zh) | 肠胃外用磷雌氮芥和磺烷基醚环化糊精制剂 | |
| CN1511037A (zh) | 非肠道使用的雌莫司汀磷酸盐和白蛋白的制剂 |